Mina is a seasoned leader in life sciences and biotechnology, with a career that bridges world-class academic research, entrepreneurial leadership, and cutting-edge AI/ML innovation. She is an experienced consortium‑level grant leader and program director who has successfully managed multi‐institutional NIH grants, overseeing cross‐functional teams across research, operations, and compliance. She combines deep expertise in strategic grant writing, budget management, stakeholder coordination, and ensuring scientific rigor with timely deliverables. Her leadership has led to securing competitive NIH funding and sustaining large collaborative projects, ensuring alignment between scientific aims, regulatory requirements, and consortium partner capacities.

Caroline has a strong knowledge on assay development, harmonization, and advanced data analysis. She plays a key role in multi‑center immune profiling efforts (e.g. CyTOF / mass cytometry) including standardizing protocols, instrumentation, and reagent use across labs to ensure high reproducibility of complex cellular assays. She integrates rigorous assay methodology with statistical evaluation of assay performance and discovery by ensuring that assay data are reliable, comparable across centers, and suitable for downstream bioinformatic interpretation.

Patricia is the lead researcher on projects involving in vitro human hematopoietic and immunological cells . She integrates stem cell biology, hematopoiesis, and immunology, and involves the use of cutting-edge high-content single-cell analytical techniques such as CyTOF and MIBI. Her work combines assay development, rigorous experimental design, and robust data analysis, enabling reproducible, high‑quality outcomes in complex biological systems.

Christine has worked in a variety of labs including industrial enzyme engineering and dermatopathology. She has managed many spatial biology projects (MIBI and MALDI platforms). Her strength focus includes project management and computational analysis pertaining to projects focused on immune profiling to identify biomarkers in various immunotherapy trials.

Olga Vilenski combines scientific rigor with pragmatic leadership to guide new product introductions from concept through production. Her ability to manage timelines, coordinate diverse teams, and align technical, quality, and operational objectives makes her a highly effective leader in driving challenging projects to successful outcomes. Her experience spans roles in research & project management at Stanford University and Roche.

Vida is a seasoned expert in nonprofit financial management, known for her deep understanding of the unique fiscal challenges and opportunities facing mission-driven organizations. With years of hands-on experience navigating budgets, audits, grant compliance, and financial reporting, Vida brings clarity and strategy to every balance sheet she touches. Her approach blends financial rigor with a passion for impact, helping nonprofits build sustainable, transparent, and accountable financial practices that align with their values and long-term goals.